Anchor Therapeutics
67 Rogers Street
Cambridge
Massachusetts
02142
United States
Tel: 617-715-1999
Fax: 617-715-7906
Website: http://www.anchortx.com/
10 articles about Anchor Therapeutics
-
Anchor Therapeutics Enters Into Collaborative Research Agreement With Kyowa Hakko Kirin for its Pepducin Technology
7/31/2012
-
Anchor Therapeutics Achieves Milestone in GPCR Collaboration
1/10/2011
-
Anchor Therapeutics Announces Collaboration with Ortho-McNeil-Janssen Pharmaceuticals, Inc., Potential $480 Million in Milestones
9/9/2010
-
Anchor Therapeutics Nabs $10M for New Class of Peptide Drugs Against Hard Targets
8/20/2010
-
Anchor Therapeutics Adds Global Experts to Board of Directors and Scientific Advisory Board
7/21/2010
-
Ascent Therapeutics Changes Name to Anchor Therapeutics
3/30/2010
-
Ascent Therapeutics Achieves Preclinical in vivo Proof-of-Principle with Novel Pepducin(TM) GPCR Modulator Platform and Strengthens Senior Management Team
9/11/2009
-
Ascent Therapeutics Appoints Industry Leaders to Senior Management Team
6/3/2009
-
Massachusetts Biotechnology Council, Inc. Release: 19 Biotech Companies Selected to Present at 10th Annual MassBio Investors Forum
12/2/2008
-
Ascent Therapeutics Debuts with the Appointment of CEO; $19 Million Series A
11/18/2008